WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC.

Tumor-infiltrating CD4 + T cells tended to increase in tumors treated with AZD1775 plus anti-PD-L1 antibody, but this did not reach statistical significance ( Figure S5C ).

also in 111,027 other papers